Apr 1, 2026
Danyang, China | November 24, 2025
Akeso recently welcomed senior representatives from municipal government and regional development authorities for an in-depth visit to its headquarters in Danyang. The delegation aimed to better understand Akeso’s contributions to technological innovation and the transformation of the global eye care industry.
During the visit, Akeso’s leadership team shared insights into the company’s growth, proprietary technologies, and future development strategy. As a technology-driven CDMO specializing in ophthalmic and optometric devices, Akeso provides end-to-end R&D, engineering, and manufacturing solutions for global partners across the eye health sector.
With core competencies spanning optical system design, micro and nano-structure fabrication, advanced materials, and AI-driven vision modeling, Akeso supports both startups and established medical device companies in bringing next-generation vision care products to market.
Dr. Make Di, Akeso’s Chief Technology Officer, introduced the company’s signature photolithography platform—adapted from the semiconductor industry for use in lens manufacturing. This high-precision, maskless lithography process has opened new frontiers in myopia control, lens design accuracy, and personalized visual solutions.
The visiting delegation toured Akeso’s research laboratories, cleanroom production lines, and ISO-certified quality management infrastructure. Government leaders and development zone officials praised the company’s ability to combine scientific innovation with scalable, high-precision manufacturing.
Representatives from the Danyang Science and Technology Bureau noted Akeso’s leading position in China’s growing medical optics sector and highlighted its expanding influence in global ophthalmic innovation.
Government officials emphasized the critical role of innovation-driven enterprises in advancing public health and economic development. They reaffirmed their support for Akeso’s mission by encouraging further collaboration across academia, healthcare institutions, and industrial partners. The delegation encouraged Akeso to expand its partnerships and deepen its investment in R&D to reinforce China’s leadership in the global vision care economy.
The visit underscored growing institutional confidence in Akeso’s capabilities and future direction. Moving forward, the company remains dedicated to delivering cutting-edge solutions in myopia management, intelligent optics, and precision-engineered vision systems.
By combining photolithographic manufacturing, AI-based lens modeling, and advanced materials, Akeso aims to set new standards for product performance and patient outcomes. Its mission remains clear: to support medical device partners worldwide with quality, innovation, and technical excellence—driving the next generation of vision care technologies.
Akeso Eyecare is a doctor-founded eye-technology company and CDMO focused on improving vision care. We design and build advanced solutions like AR displays for myopia prevention, eye tracking, extended reality devices, and digital vision health tools used in eye care and smart technology.
Our mission is to improve global vision health through smart innovation. By combining optical design, materials science, and AI, our R&D team supports partners from early research to custom design, manufacturing, and large-scale production, always guided by medical expertise, collaboration, sustainability, and patient-first thinking.
Akeso – engineering the future of vision.
Engineering the
Future of Vision.